Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial'

Ann Rheum Dis. 2023 Mar;82(3):e67. doi: 10.1136/annrheumdis-2020-219666. Epub 2021 Jan 27.
No abstract available

Keywords: biological therapy; sjogren's syndrome; therapeutics.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Letter
  • Comment

MeSH terms

  • Double-Blind Method
  • Humans
  • Receptors, Interleukin-6
  • Sjogren's Syndrome* / drug therapy
  • Treatment Outcome

Substances

  • Receptors, Interleukin-6